Susan Hasty, Publisher
Table of Contents . . . October 31st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Hepatitis B Transmission - Viral heterogeneity may produce intrauterine hepatitis B virus infection
Liver Transplantation - Thymoglobulin may prevent liver graft rejection and hepatitis C recurrence
Prison Health - Hepatitis B and C virus infections flourish among reincarcerated females
Transplant Medicine - Hepatitis B immunoglobulins avert acute rejection after liver transplantation
Transplant Medicine - Hepatitis C HVR1 quasispecies variants and CD81 change after liver transplants
Cardiology - Divergent factors control hepatitis C-related cardiomyopathy
Cell Biology - The mitogenic effect of TWEAK in liver oval cells may foster liver injury
Chronic Hepatitis B - The hepatitis B virus genome changes vary in youth who receive lamivudine
Clinical Trials - Trial of human monoclonal antibodies treatment for hepatitis C initiated
DNA Research - The expression of neuritin, a GPI-anchored protein, increases with liver development
Diabetes Risk Factors - Steatotic grafts raise the risk for new-onset diabetes in liver transplant patients
Diagnostics - Alanine aminotransferase measures liver status in hepatitis C-positive renal transplant recipients
Diagnostics - Albumin dialysis may improve mitochondrial function in patients with hepatitis C
Diagnostics - Researchers' findings advance diagnostics research
Drug Development - Hepatitis C clinical trial initiated to test NeuGene antisense compound
Drug Development - Interim results in phase II trial of Virostat show the drug is active against hepatitis C
Drug Resistance - Expression of drug transporters does not correlate to their expression in the intestine and liver
Finance - Pharmaceutical company raises GBP 750,000 for preclinical development of interferon alpha-8
Gene Research - Australian broad patent issued covering siRNAs targeting Huntington disease
Hepatitis B Vaccine - Booster vaccination against hepatitis B not necessary for long-term protection
Hepatitis B Virus - Drug resistant highly replicative hepatitis B strains associate with acute exacerbations
Hepatitis C - Genotype 1 hepatitis C virus patients treated with VX-950 reduce alanine aminotransferase levels
Hepatitis C Risk Factors - Non-commercial tattooing raises the risk for hepatitis C among non-injecting drug users
Hepatitis C Virus - New research in the area of hepatitis c virus detailed
Hepatitis C Virus - Shorter course of combination therapy approved in E.U. for some hepatitis C patients
Hepatology - Anthropometric indices parallel liver pathology in non-alcoholic fatty liver disease
Imaging - High-resolution spectroscopy successfully assesses liver biopsy samples
Liver Disease - Feedback loop found that could forestall liver damage
Liver Transplantation - Hepatitis C viral load recedes when immunosuppressive therapy is switched
Oncology - Southern African Blacks with hepatitis B-related liver cancer lack beta-catenin gene mutations
Renal Transplantation - Hepatitis B surface antigen-positive renal donors support similarly infected recipients
Renal Transplantation - Hepatitis C disappears after immunosuppressive therapy ceases
Stroke - Eyes may provide a window to future strokes
Tissue Engineering - Extracellular matrix-enriched polymeric scaffolds favor hepatocyte survival
Tissue Engineering - Liver organogenesis system shows higher levels of hepatic function
Transplant Medicine - Hepatitis B core antibody-positive kidneys could expand donor pools
Transplant Medicine - Mycophenolate mofetil monotherapy benefits liver transplant recipients
Transplant Medicine - Researchers describe findings in transplant medicine studies
Vaccine Policy - Immunocompetent travelers rarely require hepatitis A or B booster shots
Virology - Hepatitis C virus RNA in saliva does not reflect oral health or viral load
Virology - Hepatitis C virus core protein-mediated cell cycle alterations may trigger disease
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.